Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 8,000 shares at $15.68 ($125K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Open-market sale of $125k CGEM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-02-26 | $25K | — | Filing → |